Dermata Therapeutics Inc.
13F holders, Q1 2024 (March 31)7holders
1famous investor
$0.40avg. 13F price*
At the end of Q1 2024, 7 institutions reported holding Dermata Therapeutics Inc. in their 13F filings. The largest holders were Two Sigma Securities, LLC ($8K), Citadel Advisors ($7K) and Acadian Asset Management LLC ($7K). One famous investor held it Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Dermata Therapeutics Inc.
- CUSIP
- 249845306
- Latest filing quarter
- Q1 2024
Total Exit/New Position Q1 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 3 | $15K |
| Exits | 2 | $141K |
Ownership 7 holders
| Two Sigma Securities, LLC | 0.00% | New | 19,968 | $8K |
| Citadel Advisors | 0.00% | New | 17,490 | $7K |
| Acadian Asset Management LLC | 0.00% | Reduce -65.1% | 19,253 | $7K |
| Geode Capital Management, LLC | 0.00% | No change | 12,237 | $5K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -10.6% | 5,738 | $2K |
| Wells Fargo & Company | 0.00% | Add +0.3% | 705 | $289 |
| Northwestern Mutual Wealth Management Co. | 0.00% | New | 14 | $6 |
"% of holder's portfolio" is DERMATA THERAPEUTICS INC's weight in each manager's 13F, not the share of Dermata Therapeutics Inc. the manager owns.